These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 29459867)

  • 1. The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases.
    Nisini R; Poerio N; Mariotti S; De Santis F; Fraziano M
    Front Immunol; 2018; 9():155. PubMed ID: 29459867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunostimulatory and antigen delivery properties of liposomes made up of total polar lipids from non-pathogenic bacteria leads to efficient induction of both innate and adaptive immune responses.
    Faisal SM; Chen JW; McDonough SP; Chang CF; Teng CH; Chang YF
    Vaccine; 2011 Mar; 29(13):2381-91. PubMed ID: 21300103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems.
    Patel GB; Sprott GD
    Crit Rev Biotechnol; 1999; 19(4):317-57. PubMed ID: 10723627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid Nanoparticle-mRNA Formulations for Therapeutic Applications.
    Wang C; Zhang Y; Dong Y
    Acc Chem Res; 2021 Dec; 54(23):4283-4293. PubMed ID: 34793124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simple nanoliposomes encapsulating
    Bo R; Sun Y; Zhou S; Ou N; Gu P; Liu Z; Hu Y; Liu J; Wang D
    Int J Nanomedicine; 2017; 12():6289-6301. PubMed ID: 28894367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal drug delivery systems: an update review.
    Samad A; Sultana Y; Aqil M
    Curr Drug Deliv; 2007 Oct; 4(4):297-305. PubMed ID: 17979650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposome-based immunity-inducing systems for cancer immunotherapy.
    Yuba E
    Mol Immunol; 2018 Jun; 98():8-12. PubMed ID: 29128232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective Retinal Penetration of Lipophilic and Lipid-Conjugated Hydrophilic Agents Delivered by Engineered Liposomes.
    Lee J; Goh U; Lee HJ; Kim J; Jeong M; Park JH
    Mol Pharm; 2017 Feb; 14(2):423-430. PubMed ID: 27936751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-sensitive polymer-modified liposome-based immunity-inducing system: Effects of inclusion of cationic lipid and CpG-DNA.
    Yoshizaki Y; Yuba E; Sakaguchi N; Koiwai K; Harada A; Kono K
    Biomaterials; 2017 Oct; 141():272-283. PubMed ID: 28704679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular adjuvants based on nonpyrogenic lipophilic derivatives of norAbuMDP/GMDP formulated in nanoliposomes: stimulation of innate and adaptive immunity.
    Knotigová PT; Zyka D; Mašek J; Kovalová A; Křupka M; Bartheldyová E; Kulich P; Koudelka Š; Lukáč R; Kauerová Z; Vacek A; Horynová MS; Kozubík A; Miller AD; Fekete L; Kratochvílová I; Ježek J; Ledvina M; Raška M; Turánek J
    Pharm Res; 2015 Apr; 32(4):1186-99. PubMed ID: 25630814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin delivery of a hybrid liposome/ISCOM vaccine implicates a role for adjuvants in rapid modulation of inflammatory cells involved in innate immunity before the enhancement of adaptive immune responses.
    Chin J; San Gil F
    Immunol Cell Biol; 1998 Jun; 76(3):245-55. PubMed ID: 9682968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-Responsive Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response.
    Liu Q; Chen X; Jia J; Zhang W; Yang T; Wang L; Ma G
    ACS Nano; 2015 May; 9(5):4925-38. PubMed ID: 25898266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cationic liposomes as vaccine adjuvants.
    Christensen D; Korsholm KS; Andersen P; Agger EM
    Expert Rev Vaccines; 2011 Apr; 10(4):513-21. PubMed ID: 21506648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal drug delivery systems: from concept to clinical applications.
    Allen TM; Cullis PR
    Adv Drug Deliv Rev; 2013 Jan; 65(1):36-48. PubMed ID: 23036225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albumin-Encapsulated Liposomes: A Novel Drug Delivery Carrier With Hydrophobic Drugs Encapsulated in the Inner Aqueous Core.
    Okamoto Y; Taguchi K; Yamasaki K; Sakuragi M; Kuroda S; Otagiri M
    J Pharm Sci; 2018 Jan; 107(1):436-445. PubMed ID: 28826882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposome-based delivery system for vaccine candidates: constructing an effective formulation.
    Giddam AK; Zaman M; Skwarczynski M; Toth I
    Nanomedicine (Lond); 2012 Dec; 7(12):1877-93. PubMed ID: 23249332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing of 'intelligent' liposomes for efficient delivery of drugs.
    Voinea M; Simionescu M
    J Cell Mol Med; 2002; 6(4):465-74. PubMed ID: 12611636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining different types of multifunctional liposomes loaded with ammonium bicarbonate to fabricate microneedle arrays as a vaginal mucosal vaccine adjuvant-dual delivery system (VADDS).
    Wang N; Zhen Y; Jin Y; Wang X; Li N; Jiang S; Wang T
    J Control Release; 2017 Jan; 246():12-29. PubMed ID: 27986552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatic action of phospholipase A₂ on liposomal drug delivery systems.
    Hansen AH; Mouritsen OG; Arouri A
    Int J Pharm; 2015 Aug; 491(1-2):49-57. PubMed ID: 26056930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.